All of this means it's unlikely Viking will upset the market's current leaders. That said, this newer biotech player could eventually carve out a spot if all continues to go well in clinical studies.

In a speech at President Donald Trump’s inaugural rally, Musk raised his right arm in the air twice in a row in a gesture some compared to a Nazi salute. The Village People—the band behind one ...

UK biotech Bicycle Therapeutics has raised £40 million ($52m) in a new funding round to help it progress its pipeline, including its lead compound, a first-in-class cancer treatment. The company ...

Legendary supercar builder Gordon Murray has plans beyond the T.50 and T.33 variants. In a recent appearance on Autocar podcast, Murray revealed that a new model built on a new architecture is ...

Bicycle's immuno-oncology pipeline is headed by BT7480, a tumour-targeted immune cell agonist (TICA) that binds to Nectin-4 on cancer cells and stimulates CD137 on immune cells, driving an immune ...

Novak Djokovic has admitted he's not sure whether his partnership with Andy Murray will continue past the Australian Open, but a leading tennis expert has explained why it might be beneficial to ...

GSK Plc CEO Emma Walmsley talks about buying US cancer biotech IDRx for as much as $1.15 billion, expanding their portfolio ...

ARIZONA -- The Arizona Cardinals are set to play their season finale against the San Francisco 49ers later today at State Farm Stadium, and quarterback Kyler Murray is close to earning a $750,000 ...

33 GMA will then launch a different type of car boasting a new platform The U.K.'s Gordon Murray Automotive (GMA) will unveil a more track-focused “s” version as the third and final version of ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Novak Djokovic has credited rival-turned-coach Andy Murray with bringing a “fresh look” to his game ahead of the start of the 2025 season. Having played Murray 36 times in ATP events and ...

No Oxular employees are joining Regeneron, though several will be “helping short-term with tech transfer and transition work in consulting roles,” a Regeneron spokesperson told Fierce Biotech ...